National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

7.6 Major clinical issues with psychosis and stimulant (including methampetamine) use

prev pageTOC |next page

Table of contents

7.6.1 Effects of stimulants on psychotic disorders

Prevalence

Stimulant induced disorders

Stimulant use in people with chronic psychosis

Top of page

7.6.2 Interactions between stimulants and therapeutic agents for psychotic disorders

Top of page

7.6.3 Management approaches to comorbid psychotic disorders and stimulant use

Assessment

Treatment

Acute psychotic episode

Longer term psychotic episode

For further information please consult:
Guidelines for the medical management of patients with methamphetamine-induced psychosis:
http://www.dassa.sa.gov.au/webdata/resources/files/Psychosis_guidelines.pdf

prev pageTOC |next page